Form4insider filings, from the source

SEC Form 4 · accession 0000059478-17-000074

ELI LILLY & Co · LLY

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Susan Mahony
Officer — SVP & Pres., Lilly Oncology
Period of report
Feb 1, 2017
Accepted (ET)
Feb 3, 2017 · 3:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000059478

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockFeb 1, 2017M9,732$0.00A96,040D
Common StockFeb 1, 2017F4,570$77.03D91,470D
Common Stockholding———1,684I401(k)
Common StockF1holding———1,673I401(k) - by husband
Common StockF1holding———13,509Iby husband

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitF2—Feb 1, 2017M9,732DFeb 1, 2017Feb 1, 2017Common Stock9,7320D

Explanation of responses